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Abstract
Objective: The aim of this prospective study was to investigate
the diagnostic value of quantitative skeletal muscle ultrasonog-
raphy in children suspected of having a mitochondrial disorder.
Methods: Muscle thickness and quantitatively determined echo
intensity of four muscles were established in 53 children with
symptoms indicative of a mitochondrial disorder. Results: A sen-
sitivity of 25 to 46% was found, depending on the chosen cut-off
point (abnormal or borderline abnormal), with a specificity of 85
to 100%. Except for one, all abnormal ultrasound scans were
found in children over five years of age. Within the group of pa-
tients with a mitochondrial disorder, a significant correlation
was found between muscle echo intensity and age (r = 0.38;
p = 0.047). Conclusions:We conclude that skeletal muscle ultra-
sound can be of additional value in the diagnosis of childrenwith
suspected mitochondrial disorders, especially in children over
five years of age. With its low sensitivity, it is not suitable for
screening purposes. However, since all abnormal ultrasound
scans were found in children with a mitochondrial disorder, and
no significant correlationwith the MDC score was found, muscle
ultrasound can be used complementary to this scoring system to
facilitate the decision-making in pursuing further invasive diag-
nostics.
Key words
Mitochondrial disorders · muscle ultrasound · children · diagnos-
tic value
Introduction
Oxidative phosphorylation (OXPHOS) is the major source of en-
ergy production of the cell, and takes place in the mitochondria.
Mitochondrial disorders are the most common inborn errors of
metabolism with an estimated frequency of 1 :10000 live birth
[23]. Due to the central role of mitochondria in energy metab-
olism, mitochondrial diseases are often multi-organ disorders
with predominant involvement of brain and muscles [25]. To di-
agnose defects in OXPHOS, muscle is the tissue of choice to be
examined. As the collection of a muscle specimen requires an in-
vasive procedure, it would be desirable to have a diagnostic in-
strument to determine if these invasive investigations are requir-
ed.
Previous investigations have demonstrated that some patients
with mitochondrial myopathies showed marked atrophy and
fatty infiltration on CT or MRI, which was correlated with an in-
creased fatty infiltration in themuscle biopsy [5,14,18,31]. How-
ever, these investigations have mainly been limited to adults
with specific mitochondrial DNA mutations.
In children, imaging studies of skeletal muscles have predomi-
nantly been performed with ultrasonography because of its
non-invasive nature and the avoidance of sedation. Neuromus-
cular disorders generally cause increased muscle echo intensity,
which correlates positively with the infiltration of fat and fibrous
tissue [8,22]. Although this technique has proven to be a very
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sensitive method to detect structural changes in muscles caused
by neuromuscular disorders in general [9,19,32], lower sensitiv-
ities can be expected in the subgroup of mitochondrial myop-
athies, since children with mitochondrial myopathies rarely
show structural changes in muscle biopsy. However, up to 70
percent of these patients did show an abnormal ultrasound scan,
suggesting that muscle ultrasonography could also be helpful in
the diagnosis of these patients [3,9,19]. One could hypothesize
that in these patients, the shortage of energy production of the
muscle could lead to metabolic stress, resulting in muscle dam-
age, which would be visible on muscle ultrasound, as it is in
adults on other image modalities. But until now, the diagnostic
value of skeletal muscle ultrasonography in children with sus-
pected mitochondrial disorders has never been systematically
investigated.
The purpose of this prospective study was therefore to investi-
gate the diagnostic value of skeletal muscle ultrasound in chil-
dren with suspected mitochondrial disorders. We hypothesized
that its sensitivity is correlated to the age of the child and the
type and severity of the mitochondrial disorder: Older age and
more severe biochemical abnormalities might be correlatedwith
a higher number of structural changes in the muscle [13,16]. We
therefore correlated our findings to the age of the patient, type of
mitochondrial disorder, severity of symptoms and biochemical
abnormalities.
Methods
Patients
Between May 2004 and September 2005, we prospectively in-
cluded 53 children referred to our tertiary centre for metabolic
disorders, because of a suspected mitochondrial disorder. The
study was approved by the local ethics committee, and informed
consent was obtained of all parents and patients when older
than 12 years of age. As part of the regular work-up in children
with a suspected disorder in the oxidative phosphorylation we
analysed the blood lactate (multiple measurements) and pyru-
vate levels, blood gas, serum acyl-carnitine, serum and urine
amino acid profile, urine organic acid profiles. Cerebral spinal
fluid investigations were performed depending on the presence
of central nervous system involvement. Furthermore, the pa-
tients underwent a diagnostic protocol ofmultiple investigations
including ECG, chest X-ray, EEG, visual evoked potentials, acous-
tic evoked potentials, sensory evoked potentials and a cerebral
MRI. Muscle ultrasonography was performed in this initial eval-
uation phase of the diagnostics.
Based on a previous prospective clinical and biochemical study a
consensus mitochondrial disease criteria (MDC) scoring system
has been established to facilitate the diagnosis in patients with
a suspected mitochondrial disorder. The MDC score is positively
correlated to the likelihood of a mitochondrial disorder, con-
firmed by the biochemical abnormalities measured in a fresh
muscle biopsy [30]. The MDC system uses a combined scoring
of muscle symptoms (maximal score: 2 points), CNS abnormal-
ities (maximal score: 2 points) and multi-system involvement
(maximal score: 3 points) with a maximal total clinical score of
4 points, and the addition of metabolic abnormalities and the re-
sults of the neuroimaging (maximal additional score: 4 points).
Specific histologic anomalies found at the time of the biopsy
might increase the final MDC score further with 4 points, leading
to a total maximal score of 12 points [30]. The scoring system
was originally established as a method to achieve the final clini-
cal diagnosis. In case of a high clinical/metabolic section of the
MDC score, the application of the criteria facilitates the decision
making in the further diagnostic steps already prior to the
muscle biopsy. Conversely, a lowMDC score makes the presence
of mitochondrial dysfunction very unlikely. In the present study
we used the MDC score to clinically evaluate mitochondrial dys-
function. If a patient had a MDC score lower than 3 or improving
clinical signs, a muscle biopsy was not performed. If a patient
had a MDC score of 3 points or higher we performed a muscle bi-
opsy to confirm the diagnosis on the biochemical level.
Muscle biopsy and biochemical analysis
After the initial evaluation, the patient’s clinician decided
whether an open muscle biopsy was indicated, based on the
MDC score (3 or higher), the presence of persistent and/or pro-
gressive symptoms and the eventual familial occurrence of the
symptoms. Muscle biopsy was performed under general anaes-
thesiawithin threemonths. In childrenwith a spontaneously im-
proving clinical picture and decreasing MDC scores the biopsy
was postponed and further follow-up was initiated. Due to the
prospective nature of the study, both groups of patients (with or
without a muscle biopsy) were included for further analysis.
A part of each muscle biopsy was used for histopathological ex-
amination. Frozen muscle sections were stained according to
standard histological and enzyme histochemical methods and
were evaluated for evidence of mitochondrial disorders (COX
negative or COX deficient fibres and ragged-red fibres) and other
neuromuscular disorders. Since structural abnormalities like
fatty infiltration and fibrosis may correlate with abnormal
muscle ultrasonography, percentage of fat cells and percentage
perimysial tissue (for the larger part containing connective tis-
sue, but also blood vessels and nerve bundles may be present)
were measured for each muscle biopsy. Pictures from Sudan
Black B stained sections served to determine the fat cell area. Tri-
chrome stained sections were used for perimysial tissue mea-
surements. For both measurements a systematic random point
sampling design was used. The results were obtained by sum-
ming the points covering the fat cell area or connective tissue
area in relation to the respective total area of the biopsy section.
Detailed biochemical investigations, including substrate oxida-
tion rates (pyruvate, malate, succinate), ATP production rate
from pyruvate oxidation and the activity of the mitochondrial
complexes I, II, III, IV, V and PDHc were measured in a fresh
muscle sample according to previously described methods
[10,11,29].
Molecular genetic analysis
Mutation analysis of theMELAS 3243A>G, MERRF 8344A>G and
Leigh/NARP 8993T>C, sequence analysis of themtDNA formuta-
tions in the genes ND1, ND2, ND3, ND4, tRNA Leu (uur) and tRNA
Lys, long template PCR analysis for mitochondrial deletions and
sequence analysis of the nuclear encoded PDHA1, SURF1, NDUSF1,
NDUSF2, NDUSF4, NDUSF7 and NDUVF1 genes were performed in
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the patients diagnosed with a definite mitochondrial disorder,
appropriate to the clinical presentation and the detected bio-
chemical alterations.
Gold standard
Since the underlying mutation is only discovered in the minority
of pediatric patients with mitochondrial disorders [23,26], we
applied a functional-biochemical definition to validate muscle
ultrasonography. Based on biochemical evaluation and muscle
biopsy, the childrenwere assigned to the following groups:
1. Mitochondrial disorder:
a) definite: decreased pyruvate oxidation rate, ATP production
rate, and at least one enzyme complex activity below the
control range
b) possible: decreased pyruvate oxidation rate, ATP production
rate below the control range but normal enzyme complex ac-
tivities
2. Nomitochondrial dysfunction:
a) excluded on the biochemical level (with muscle biopsy)
b) no mitochondrial dysfunction suspected/no biopsy requested:
lowMDC score, improvement of clinical signs.
3. Other diagnosis.
Skeletal muscle ultrasound measurement
In all patients an ultrasound measurement was obtained before
the diagnosis had been established and before a muscle biopsy
had been performed. The investigatorwas blinded for the clinical
presentation and the results of other investigations. The method
of ultrasound scanning is described in detail in a previous study
of our group [24]. As the ultrasound measurement might be ap-
plied as a screening tool, a short protocol was chosen, in which
four muscles were selected for examination: two proximal, two
distal, in both arms and legs (biceps brachii, forearm flexors,
quadriceps femoris, and tibialis anterior muscle). With this pro-
tocol, all measurements could be performed within 15 minutes.
All muscles were examined in the transverse plane. A phased ar-
ray real-time scanner (Sonos 2000 Phased Array Imaging Sys-
tem; Hewlett-Packard Company, Andover, Massachusetts, USA)
was used, with a 7.5MHz transducer. All system-setting param-
eters were conform our previous study, to be able to use the es-
tablished normal values (gain 86 dB, compression 70 dB, no ad-
justments in time gain compensation or focus). The images were
digitized and stored as “tagged image file format” (TIFF) files
with a resolution of 800 × 600 pixels with 256 grey-levels. Three
consecutive measurements were taken of every muscle and re-
sults were averaged. After each measurement the patient was al-
lowed to move and the transducer was repositioned. During the
examination of themuscles, carewas taken tomaintain the same
standardized position of the child and the exact location of the
transducer as described in our previous study with healthy chil-
dren [24]. Muscle thickness was measured with electronic cal-
lipers during the examination. Echo-intensity (EI) was deter-
mined using computer-assisted grey-scale analysis. In each im-
age, the entire muscle was selected just within the borders of
the muscle. In the quadriceps muscle, the rectus femoris muscle
was chosen for analysis of EI, as in severe neuromuscular disor-
der the outlines of the vastus intermediusmuscle can be difficult
to define [7]. The mean EI of this region was then calculated us-
ing the standard histogram function of Adobe Photoshop (Adobe
Systems Inc., San Jose, California, USA).
As muscle echo intensity is different for each muscle and muscle
thickness is dependent on weight [24], it has to be standardized
to be able to compare individual patients and muscles. The
measurements were therefore compared with normal values, es-
tablished in a previous study [24], and transformed into z-scores
(expressed in standard deviations from normal, SD), using the
following equation:
z score SD  measured valuenormal valuestandard deviation of normal value
Statistical analysis
Our data were analyzed with the SPSS package for Windows
12.0.1 (SPSS Inc., Chicago, Illinois, USA) and statistical signifi-
cance was defined as p value ≤ 0.05. The standardized echo in-
tensity and muscle thickness were compared to normal using a
one-sample t-test, and compared between patients with a mito-
chondrial disorder (definite and possible) and patients without a
mitochondrial disorder using an independent samples Mann-
Whitney U test.
Sensitivity and specificity were determined after applying two
cut-off points:
– An abnormal ultrasound measurement was defined as one
very abnormal muscle (z-score > 3.5 SD) or 2 abnormal
muscles (> 2.5 SD) or 3 slightly abnormal muscles (> 1.5 SD).
– A normal ultrasoundmeasurementwas defined as all muscles
below 2.0 SD and threemuscles below 1.5 SD and twomuscles
below 1.0 SD.
– Between these cut-off points, the ultrasound measurement
was called borderline abnormal.
These cut-off points were chosen because, in this way, both pa-
tients with selective muscle involvement and patients with gen-
eralizedmuscle involvement would be detected with the highest
predictive values.
To determine the cause of increased echo intensity in patients
with mitochondrial disorders, the sum of all muscles were cor-
related to age, initial MDC-score, ATP production, and percentage
fat and fibrous tissue in the muscle biopsy. Two combined terms
were added because of the hypothesis that both age and severity
of the disorder would determine the amount of muscle damage:
MDC × age and ATP/age. The correlations were determined with
a Pearson’s correlation coefficient.
Results
Forty-eight children were assigned to the diagnostic groups as
follows: Twenty-eight children had a definite or possible mito-
chondrial disorder; seventeen children did not show any evi-
dence of a mitochondrial disorder. In the group of the children
with a definite mitochondrial disorder one patient was diag-
nosed with a common ATPase 6 mtDNA mutation, and another
one with a nuclear-encoded homozygous SURF1 mutation. The
three remaining patients were diagnosed with Prader-Willi syn-
drome (n = 1) or a chromosome disorder with secondary mito-
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chondrial dysfunction (n = 2). Table 1 summarizes the results of
the diagnostic evaluation. Five children were excluded from fur-
ther analysis: one child was lost to follow-up; muscle biopsy was
indicated but postponed in four children due to a significant
spontaneous improvement or social problems.
Muscle thickness of all muscles, except for the forearm flexors,
was significantly decreased in all patients, with or without a mi-
tochondrial disorder, but was not significantly different between
patients with andwithout amitochondrial disorder. Muscle echo
intensity was significantly higher in all muscles, except for the
forearm flexors, in patients with a mitochondrial disorder com-
pared to patients without a mitochondrial disorder (Table 2).
Fig.1 shows an example of two ultrasound scans of the quadri-
ceps.
Seven out of 28 children with a definite or possible mitochon-
drial disorder had an abnormal ultrasound scan. With the excep-
tion of one child, all these childrenwere over five years of age. Six
patients had a borderline abnormal ultrasound scan. This gives a
sensitivity of 25 to 46% depending on the cut-off point chosen
(abnormal or borderline abnormal). No child without a mito-
chondrial disorder or other diagnosis had an abnormal ultra-
sound scan; three had a borderline abnormal ultrasound scan.
This gives a specificity of 85 to 100%.
Within the group of patients with a possible or definite mito-
chondrial disorder, a significant correlation was found between
the sum of muscle echo intensity of all muscles and age
(r = 0.38; p = 0.047; Fig. 2). The MDC-score, ATP production, the
combination of these parameters with age did not correlate sig-
nificantly with muscle echo intensity. Both intramuscular fat
percentage (r = 0.34; p = 0.079) and intramuscular connective tis-
sue (r = – 0.038; p = 0.85) were not significantly correlated with
muscle echo intensity of the quadriceps muscle.
Discussion
In this prospective study, we investigated the value of muscle ul-
trasonography in the diagnostic work-up in children with a sus-
pected dysfunction in the OXPHOS. We found a sensitivity of up
to 46%, whichwas lower than the sensitivity reported in children
with other neuromuscular disorders [9,32]. With this sensitivity,
muscle ultrasound is not suitable for screening purposes since a
negative ultrasound result will not exclude amitochondrial myo-
pathy [2]. However, muscle ultrasound did showa very high pos-
itive predictive value: all abnormal ultrasound results were
found in children with a “definite” or “possible” mitochondrial
disorder. The ultrasound technique could therefore be used in
addition to other investigations and the clinical diagnostic scor-
ing system. In children with a clinically uncertain diagnostic
score, a positive ultrasound would support the decision to per-
form further, more invasive investigations (e.g. muscle biopsy).
Table 1 Diagnosis, age, MDC score, ATP production and ultrasound results of all patients
Mitochondrial disorder No mitochondrial disorder Other diagnosis*
definite possible confirmed on
biochemical level
no biopsy requested
Number of patients 13 15 7 10 3
US results (abnormal/
borderline abnormal [n])
3/2 4/4 0/1 0/2 0/0
Age (median, range [y]) 3.6 (0.9–12) 4.2 (0.7–11) 8.0 (3.6–15) 1.5 (0.01–10) 2.7 (0.2–3.0)
MDC score (median, range) 6 (3–11) 6 (3–8) 4 (1–6) 4.5 (2–6) 2; 2; 6
Number of patients with biopsy 13 15 7 0 2
ATP production (mean, range) 25 (6–43) 32 (21–40) 48 (43–70) ND 27; 34
Biopsy % fat (median, range) 0.6 (0–10) 0.4 (0–7.0) 1.9 (0–4.2) ND 0.0; 0.4
Biopsy % fibrous tissue
(median, range)
2.6 (0.4–6.7) 1.0 (0–6.5) 3.2 (1.1–14) ND 0.9; 3.3
* Prader-Willi syndrome, chromosomal disorder with secondary mitochondrial dysfunction (n = 2). ND = not determined; US = ultrasound
Table 2 Differences in muscle thickness and echo intensity be-
tween patients with and without a mitochondrial disorder
Mitochondrial
disorder
(z-score)
No mitochon-
drial disorder
(z-score)
Significance
of difference
(p-value)
Muscle thickness
Biceps brachii – 0.95 * – 1.1 * n.s.
Forearm flexors – 0.10 0.06 n.s.
Quadriceps femoris – 1.36 * – 1.33 * n.s.
Tibialis anterior – 0.44 * – 0.63 * n.s.
Echo intensity
Biceps brachii 0.39 † – 0.63 0.001
Forearm flexors 0.30 – 0.16 n.s.
Quadriceps femoris 1.46 † 0.50 † 0.010
Tibialis anterior 1.10 † 0.13 0.001
* significantly decreased compared to normal, † significantly increased compared to
normal
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In our study group, almost all abnormal ultrasound results were
found in children over five years old, indicating that the diagnos-
tic value is higher in older children. Conversely, as the sensitivity
is very low in younger children, skeletal muscle ultrasonography
is not very likely to contribute to the diagnosis in young children
with mitochondrial disorders. Moreover, based on these results
one could state that if an abnormal ultrasound result is found in
a child younger than 5 years of age, the presence of another neu-
romuscular disorder might be more likely [9,16].
Ultrasonography is a non-invasive and easily available technique
and suitable for use in children. Other imaging modalities have
also been used in the diagnosis of neuromuscular disorders in
children. The use of muscle MRI has been investigated exten-
sively in children with neuromuscular disorders [6,15,21], but,
although no prospective studies have been performed, it seems
to be less capable of detecting pathological changes in children
with mitochondrial myopathies [1,4]. Moreover, the major dis-
advantages of MRI are high costs and the prerequisite of sedation
in young or mentally retarded children.
A significant correlation between age and echo intensity was
found in the group of children with mitochondrial dysfunction,
where older children showed higher muscle echo intensities.
This is in concordance with previous investigations, in which
higher sensitivities in adults and increased alterations with age
were reported [5,14,18,20]. The defect in OXPHOS results inmet-
abolic stress during exercise, which can cause damage to DNA
and apoptosis [16], eventually leading to structural changes like
fibrosis and fatty infiltration, accumulating over years. This phe-
nomenonmay explain the increase in severity of the diseasewith
age [13]. However, the prospective nature of the study resulted in
an inclusion of younger childrenwith relatively severe and older
children with a relatively mild presentation of a mitochondrial
disorder. This probably explains the limited correlationwith age
found in this study. Another study including children with vari-
ous duration of their illness or a longitudinal study designwould
bemore appropriate to investigate if an increase in echo intensity
occurs when children with mitochondrial disorders grow older.
The absence of a significant correlation between the MDC score
and themuscle echo intensity indicates that the presence of clin-
ical symptoms and muscle involvement does not lead directly to
increased echo intensity, and that muscle ultrasound can there-
fore be used complementary to this diagnostic scoring system.
Previous studies have shown that muscle echo intensity is
strongly correlated with structural changes in themuscle biopsy,
especially fatty infiltration. However, in the present study the
correlation between percentage intramuscular fat and echo in-
Fig. 2 Correlation between age and muscle echo intensity in patients
with a mitochondrial disorder (n = 28).
Fig.1a and b Transverse ultrasound scan of the quadriceps muscle.
a normal muscle appearance of a 6-year-old patient without a mito-
chondrial disorder. b abnormal ultrasound scan with increased echo
intensity of the rectus femoris muscle. This patient, who was also six
years old, suffered from a complex I, III and V deficiency.
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tensity was not very strong, probably because only a few patients
showed a pathologically increased percentage of fat. Moreover,
the location and size of fat collections also effects echo intensity.
Structures smaller than the wavelength of the ultrasound beam
do not cause a reflection and do therefore not increase echo in-
tensity [3,8]. This fact was not taken into account in the correla-
tion calculated.
In this study, the diagnosis of most patients was based on the
clinical evaluation and confirmed with biochemical measure-
ments in a freshmuscle biopsy, which gives a sensitive, function-
al information about mitochondrial function. Since an underly-
ing gene mutation is only discovered in the minority of pediatric
patients with mitochondrial disorders, we applied this function-
al-biochemical definition to validate muscle ultrasonography. In
many adult patients, especially in the familial cases, mtDNA-de-
fects could be confirmed early on in the diagnostic phase. In chil-
dren however, most OXPHOS disorders are caused by de novo nu-
clear gene defects, most of which still await identification
[23,26,28]. However, mitochondrial function can be temporarily
or secondarily impaired due to extreme inactivity, malnutrition
or other neuromuscular disorders [12,17,27]. On the other hand,
biochemical results can be normal, even in patients with a defi-
nite disorder in OXPHOS and a knownmitochondrial DNA muta-
tion, for example if the percentage of heteroplasmy in themuscle
tissue under examination is below the threshold level that gives
rise to a detectable OXPHOS defect. This has to be taken into ac-
count when interpreting the results of our study, but could not
be avoided because of its prospective design.
We conclude that skeletal muscle ultrasound can be of additional
value in the diagnosis of children between 5 and 18 years of age
with suspectedmitochondrial disorders. With its low sensitivity,
it is not suitable for screening purposes. However, since a high
positive predictive value was found and no significant correla-
tion with the MDC score, it could be used complementary to this
scoring system to facilitate the decision-making in requesting
further invasive diagnostics.
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